Prestige Consumer Healthcare PBH
$
Relative Strength Index (RSI)
- The Relative Strength Index (RSI) is a momentum oscillator that measures the speed and change of price movements. It is typically used to identify overbought or oversold conditions in financial markets.
- The RSI is calculated using the following formula:
RSI = 100 - (100 / (1 + RS))
Where RS is the ratio of the average gains to the average losses over a specified period.
- The default time period used is 14 days.
- RSI values range between 0 and 100.
RSI values above 70 are considered overbought (indicating a potentially opportune time to sell)
RSI values below 30 are considered oversold (indicating a potentially opportune time to buy)
RSI is not a perfect indicator and should be used in conjunction with other technical analysis tools, this is for informational purposes only and is not a substitute for professional financial advice.
Key Insights
Prestige Consumer Healthcare (PBH) Core Market Data and Business Metrics
Latest Closing Price
$86.03Price-Earnings Ratio
20.93Total Outstanding Shares
49.41 Million SharesDividend
No dividendSIC Description
Pharmaceutical PreparationsPrimary Exchange
New York Stock ExchangeHeadquarters
660 White Plains Rd., Tarrytown, NY, 10591
Historical Stock Splits
| Execution Date | Split Amount |
|---|---|
| No Historical Stock Splits | |
Short Interest
Track Short Interest Levels to Gauge Bearish Market Sentiment and Short Squeeze Potential
| Avg Daily Volume | Days to Cover | Settlement Date | Short Interest |
|---|---|---|---|
| 401,464 Shares | 3.83 | 3/14/2025 | 1,536,638 Shares |
| 308,344 Shares | 4.94 | 2/28/2025 | 1,522,633 Shares |
| 403,029 Shares | 4.18 | 2/14/2025 | 1,683,586 Shares |
| 266,479 Shares | 7.77 | 1/31/2025 | 2,070,009 Shares |
| 290,589 Shares | 8.03 | 1/15/2025 | 2,333,048 Shares |
| 251,282 Shares | 10.03 | 12/31/2024 | 2,520,119 Shares |
Cash Flow Statement
October 1, 2023 to September 30, 2024
| Metric | Value |
|---|---|
| Net Cash Flow | $-8.53 Million |
| Net Cash Flow, Continuing | $-10.71 Million |
| Net Cash Flow From Investing Activities | $-23.66 Million |
| Exchange Gains/Losses | $2.18 Million |
| Net Cash Flow From Operating Activities, Continuing | $262.95 Million |
| Net Cash Flow From Financing Activities, Continuing | $-250.01 Million |
Income Statement
October 1, 2023 to September 30, 2024
| Metric | Value |
|---|---|
| Operating Income/Loss | $325.37 Million |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic | $0 |
| Benefits Costs and Expenses | $849.33 Million |
| Income Tax Expense/Benefit, Deferred | $17.71 Million |
| Income/Loss From Continuing Operations Before Tax | $261.33 Million |
| Net Income/Loss | $205.95 Million |
Comprehensive Income
October 1, 2023 to September 30, 2024
| Metric | Value |
|---|---|
| Comprehensive Income/Loss | $215.41 Million |
| Comprehensive Income/Loss Attributable To Noncontrolling Interest | $0 |
| Other Comprehensive Income/Loss Attributable To Parent | $9.46 Million |
| Comprehensive Income/Loss Attributable To Parent | $215.41 Million |
| Other Comprehensive Income/Loss | $215.41 Million |
Balance Sheet
October 1, 2023 to September 30, 2024
| Metric | Value |
|---|---|
| Intangible Assets | $2.32 Billion |
| Assets | $3.32 Billion |
| Noncurrent Assets | $2.94 Billion |
| Other Non-current Assets | $544.72 Million |
| Other Current Liabilities | $51.21 Million |
| Liabilities | $1.59 Billion |
Historical Dividends
| Announcement Date | Payment Date | Record Date | Amount | Frequency |
|---|---|---|---|---|
| No historical dividends | ||||